Charles Schwab’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Sell |
266,384
-5,495
| -2% | -$239K | ﹤0.01% | 1939 |
|
|
2025
Q1 | $10.2M | Sell |
271,879
-5,613
| -2% | -$210K | ﹤0.01% | 1946 |
|
|
2024
Q4 | $12.6M | Sell |
277,492
-2,936
| -1% | -$133K | ﹤0.01% | 1912 |
|
|
2024
Q3 | $16.5M | Buy |
280,428
+41,686
| +17% | +$2.45M | ﹤0.01% | 1801 |
|
|
2024
Q2 | $9.39M | Sell |
238,742
-2,024
| -0.8% | -$79.6K | ﹤0.01% | 2074 |
|
|
2024
Q1 | $16M | Buy |
240,766
+85,001
| +55% | +$5.65M | ﹤0.01% | 1736 |
|
|
2023
Q4 | $4.35M | Buy |
155,765
+4,407
| +3% | +$123K | ﹤0.01% | 2370 |
|
|
2023
Q3 | $3.22M | Buy |
+151,358
| New | +$3.22M | ﹤0.01% | 2437 |
|